
Constellation Pharmaceuticals, Inc. CNST
Constellation Pharmaceuticals, Inc. Total Liabilities 2011-2026 | CNST
Annual Total Liabilities Constellation Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 31.1 M | 61.5 M | 14.8 M | 11.7 M | 21.4 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.5 M | 11.7 M | 28.1 M |
Total Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
390 M | $ 3.55 | -0.28 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
395 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
5.38 M | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
7.89 M | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
119 M | $ 3.25 | 3.67 % | $ 229 M | ||
|
I-Mab
IMAB
|
707 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
62.5 M | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
6.61 M | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
20.4 M | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
126 M | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
7.8 M | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
440 M | $ 4.14 | -1.9 % | $ 105 M | ||
|
Aptorum Group Limited
APM
|
4.35 M | $ 0.79 | - | $ 4.31 M | ||
|
Midatech Pharma plc
MTP
|
6.46 M | - | -18.52 % | $ 27.3 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
57.2 M | $ 6.58 | -0.75 % | $ 180 M | ||
|
argenx SE
ARGX
|
704 M | $ 710.26 | 0.99 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
109 M | - | - | $ 86.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
5.89 M | $ 3.43 | -4.99 % | $ 8.25 B | ||
|
Ascendis Pharma A/S
ASND
|
1.47 B | $ 229.93 | -0.47 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
37.2 M | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
46.6 M | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
39.8 M | $ 6.09 | 0.58 % | $ 496 M | ||
|
BioCardia
BCDA
|
4.59 M | $ 1.31 | 2.91 % | $ 27.7 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - | ||
|
Akero Therapeutics
AKRO
|
75.8 M | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
28.4 M | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
45.1 M | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
28.4 M | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
13.8 M | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
15.9 M | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
21.9 M | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
3.45 M | $ 3.47 | -3.07 % | $ 7.55 B | ||
|
Catalyst Biosciences
CBIO
|
23.8 M | $ 11.19 | -3.41 % | $ 1 B | ||
|
Anika Therapeutics
ANIK
|
42.3 M | $ 14.61 | 1.74 % | $ 214 M | ||
|
Aptinyx
APTX
|
28.4 M | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
14.7 M | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
59.5 M | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.43 M | - | - | $ 7.46 M | ||
|
CNS Pharmaceuticals
CNSP
|
2.52 M | $ 2.36 | -3.55 % | $ 902 K | ||
|
Aytu BioScience
AYTU
|
93.3 M | $ 2.62 | -0.75 % | $ 16.5 M | ||
|
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
355 M | $ 1.51 | - | $ 385 M | ||
|
BioNTech SE
BNTX
|
2.76 B | $ 93.66 | 3.45 % | $ 27.2 B | ||
|
Athira Pharma
ATHA
|
13.9 M | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
470 M | - | - | $ 867 M | ||
|
Aravive
ARAV
|
51.5 M | - | -13.39 % | $ 1.45 M |